A detailed history of Strs Ohio transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Strs Ohio holds 67,400 shares of XERS stock, worth $229,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,400
Previous 67,400 -0.0%
Holding current value
$229,160
Previous $151,000 27.15%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$1.7 - $2.45 $11,730 - $16,905
6,900 Added 11.4%
67,400 $151,000
Q1 2024

May 13, 2024

SELL
$2.04 - $3.22 $7,752 - $12,236
-3,800 Reduced 5.91%
60,500 $133,000
Q2 2023

Jul 31, 2023

BUY
$1.82 - $2.98 $117,026 - $191,614
64,300 New
64,300 $168,000

Others Institutions Holding XERS

About Xeris Biopharma Holdings, Inc.


  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $462M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.